Wednesday, October 9, 2019

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug

Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drug The tentative nod granted by US Food Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for multiple strengths of dimethyl fumarate delayed-release capsules of 120 mg and 240 mg.

from Moneycontrol Business News https://ift.tt/2LWLFDH
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian stocks hit record highs, oil heads for weekly loss

Asian stocks reached a record high, fueled by optimism that the reopening of the Strait of Hormuz will normalize oil flows and ease inflatio...